Evotec SE - Company Profile

Powered by

All the data and insights you need on Evotec SE in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Evotec SE Strategy Report

  • Understand Evotec SE position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Evotec SE: Overview

Select Item

Evotec SE (Evotec) is a drug discovery alliance and development partnership company. It discovers and develops small molecule drugs spanning various conditions areas such as oncology, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides drug discovery services such as target identification and validation, sample management, hit identification, in vitro pharmacology services, integrated CMC, and proteomics services. The company has long-term discovery alliances with several leading pharmaceutical companies and development partnerships for product candidates in clinical and pre-clinical development stages. The company has operating facilities in Abingdon and Alderley Park, the UK; Gottingen and Munich, Germany; Orth an der Donau, Austria; Branford, Princeton and Watertown, the US; Verona, Italy; and Toulouse and Lyon, France. Evotec is headquartered in Hamburg, Germany.

 Gain a 360-degree view of Evotec SE and make more informed decisions for your business Gain a 360-degree view of Evotec SE and make more informed decisions for your business Find out more
Headquarters Germany
Address Essener Bogen 7, Hamburg, Baden-Wurttemberg, 22419
Website www.evotec.com
Telephone 49 40 560810
No of Employees 5,086
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange EVT (ETR)
Revenue (2021) $790.2M 21.6% (2021 vs 2020)
EPS XYZ
Net Income (2021) XYZ -181.5% (2021 vs 2020)
Market Cap* $2.6B
Net Profit Margin (2021) XYZ -167.1% (2021 vs 2020)
* As of and is in US$
View Evotec SE financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Evotec SE premium industry data and analytics

200+

Pipeline Drugs

Identify which of Evotec SE’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

80+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Evotec SE’s relevant decision makers and contact details.

70+

Clinical Trials

Determine Evotec SE go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Catalyst Calendar

Proactively evaluate Evotec SE’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

8

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Evotec SE’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Technologies: Drug Discovery J. DISCOVERY
J. DESIGN Target Identification and Validation J. MD
Induced Pluripotent Stem Cells (IPSC) Drug Discovery Platform Hit Identification J.POD
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Evotec SE portfolio and identify potential areas for collaboration Understand Evotec SE portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In March, the company secured a contract to provide winch equipment for a Faroese fishing vessel ordered by Vardin from the MEST yard in Torshavn, Faroe Islands.
2024 Contracts/Agreements In February, Just – Evotec Biologics, Inc. expanded its contract with Advanced BioScience Laboratories, Inc. to design highly efficient manufacturing processes for neutralising antibodies against HIV.
2024 Contracts/Agreements In January, the company entered into an agreement with the Crohn’s & Colitis Foundation to improve drug discovery for two innovative drug targets stemming from cutting-edge academic research for inflammatory bowel disease.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Evotec SE Merck & Co Inc AstraZeneca Plc Cobra Biologics Ltd Charles River Germany GmbH & Co. KG
Headquarters Germany United States of America United Kingdom United Kingdom Germany
City Hamburg Kenilworth Cambridge Keele -
State/Province Baden-Wurttemberg New Jersey England Staffordshire -
No. of Employees 5,086 72,000 89,900 134 -
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Laetitia Rouxel Chief Financial Officer; Director Executive Board 2023 -
Craig Johnstone, Ph.D. Chief Operating Officer Senior Management 2019 53
Cord Dohrmann, Ph.D. Chief Scientific Officer Senior Management 2010 59
Mario Polywka Chief Executive Officer - Interim Senior Management 2024 -
Iris Low-Friedrich Vice Chairman Executive Board 2019 63
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Evotec SE key executives to enhance your sales strategy Gain insight into Evotec SE key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward